CJ CHEILJEDANG CORPORATION

CJ CHEILJEDANG CORPORATION has been granted 709 US utility patents between 2015 and 2025, placing CJ CHEILJEDANG CORPORATION at rank #625 across all assignees tracked by PlainPatent. This portfolio spans 85 distinct Cooperative Patent Classification (CPC) subclasses, averaging 6.0 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, CJ CHEILJEDANG CORPORATION is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 57.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 455 grants, compared with 254 in the 2015–2019 window — a +79% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. CJ CHEILJEDANG CORPORATION's 6.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 85 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark CJ CHEILJEDANG CORPORATION against peers pursuing similar technology classes.